Objective To determine whether anterior prostatic tumours are adequately sampled using the Stamey sextant protocol, as a fifth of prostate cancers are anterior in distribution at radical prostatectomy. Materials and methods All tumours (62) with an anterior distribution (o75% of the tumour anterior to the urethra) on radical prostatectomy wholemounts, and in which the number and results of the sextant biopsies were available, were extracted from a prostate cancer database. Sixty-one posterior tumours (o75% of the malignant tissue posterior to the urethra) and their corresponding sextant biopsies were also retrieved for comparison. The number of biopsy sessions, the number of cores involved and the summated tumour length were recorded, together with the prostate gland weight, the tumour volume and the site of o75% of tumour in the superior-inferior axis. Results Anterior tumours required significantly more biopsy sessions to diagnose prostate cancer than posterior neoplasms (anterior, one set 47; > one set 15; posterior, one set 57; > one set, four, P=0.007).
Anterior tumours had fewer cores with tumour involvement and less summated tumour length than had posterior cancers. The mean (SD) number of positive cores was; anterior 1. 
Introduction
The standard sextant biopsy, as described by Hodge et al. [1] , is reported to miss 15-31% of prostate neoplasms ( Fig. 1 ) [2] [3] [4] [5] . In our series of 547 radical prostatectomy specimens held on the University College Hospital, London (UCL) database, the carcinoma was predominantly anterior to the urethra in 21%. The distribution of tumour seen in the whole-mount sections suggests that the effectiveness of sampling such tumours by the standard sextant protocol should be assessed. The current retrospective study addresses this quantitatively by comparing the biopsy sampling of tumours found to be predominantly anterior or posterior at radical prostatectomy.
Materials and methods
The prostate cancer database held at UCL has details on 547 radical prostatectomy specimens. Anterior prostate cancers were defined as tumours in which o75% of the malignant tissue is anterior to the urethra on radical prostatectomy whole-mount specimens ( Fig. 2 ). Cancers were also defined as basal, middle, apical or throughout the prostate, depending on the site of o75% of the neoplastic tissue in the superior-inferior axis. All tumours with an anterior distribution in which the number and results of sextant biopsies were available were retrieved from the database (62 cases). These were selected in that the preceding biopsies had been reported at UCL, either initially or on referral before radical prostatectomy. Over the same period and limited by similar criteria, 61 posterior tumours (o75% of cancer posterior to the urethra) and their corresponding sextant biopsies were extracted for comparison. Biopsies were initially taken according to the Stamey protocol [1] , and subsequent repeated sets incorporated an additional midline sample. The number of sets of sextants required to diagnose prostate cancer, the number of positive cores and the summated tumour length were recorded to assess efficacy. The gland weight, tumour volume and tumour position in the superior-inferior plane for each case were included to enable clarification of confounding factors. The Mann-Whitney U-test, chi-square and Student's t-test were used to assess differences, as appropriate.
Results
Patients who had anterior tumours on radical prostatectomy whole-mounts, when compared with those with posterior cancers, were significantly more likely to require more than one set of sextant biopsies to diagnose malignancy (P=0.007). Of the 62 patients with anterior lesions, 47 required one set, nine required two, three required three and three required four sets before prostate cancer was diagnosed pathologically. In contrast, of those with posterior tumours on radical prostatectomy, in 57 patients cancer was diagnosed on the initial biopsy and only four required an additional set for the histological diagnosis (Table 1) . There was a significant difference between the number of positive cores (P=0.001) and the summated tumour length (P=0.002) in the two groups. There was no significant difference in prostate weight (P=0.3), tumour volume (P=0.09) or site in the superior-inferior axis between the groups (Table 1) .
Discussion
The diagnosis of prostate cancer is histopathological and is usually made from TRUS-guided needle biopsies [1, 6] . The sextant biopsy was introduced in 1989, by Hodge et al. [1] , who described taking six biopsies from the parasagittal line halfway between the midline and the lateral border of the prostate. Stamey [7] modified this technique, shifting the biopsies laterally to adequately sample the anterior horn of the peripheral zone. In the present study, using the Stamey technique, anterior tumours were more difficult to detect than posterior neoplasms. Men with anterior lesions are more likely to require multiple sets of biopsies to produce a diagnosis of prostate cancer. The cancer yield is lower, with on average fewer cores involved and less total tumour length (Fig. 3) .
In the overall series, 21% of prostate cancers were predominantly anterior in distribution, 57% were predominantly posterior and 22% were distributed in both regions. Anterior tumours therefore comprise a significant proportion of prostate cancers. Prostate cancers were more frequently found in the apex of the gland, but there was no difference between the incidence of anterior and posterior lesions and their superior-inferior location.
The anterior compartment of the normal prostate contains the anterior horns of the peripheral zones, the anterior transition zone and the fibromuscular area; all may contain glandular elements [8] . Chen et al. [9] designed a stochastic computer-simulation model to test biopsy strategies. They mapped a total of 607 tumours from the whole-mounts of 180 radical prostatectomy specimens and designed a computer program to simulate the biopsy. The standard sextant biopsy [1] detected 73% of tumours >0.5 mL and only 18% of tumours of <0.5 mL. Tumours not sampled adequately were in the anterior transition zone superior and lateral to the urethra, the inferior part of the anterior horn where the peripheral zone envelops the transition zone, and the midline of the peripheral zone. When simulated biopsies were taken in these areas a further 70% of cancers previously missed were detected, the anterior horn having the highest detection rate, followed by the transition zone and midline, respectively. Further improvements in prostate cancer detection have been reported by increasing the number and sites of biopsies [10] [11] [12] [13] . Levine et al. [10] took two consecutive sextant biopsies at the same visit and reported a 30% increase in cancer detection. Eskew et al. [11] compared the standard sextant technique to a five-region biopsy scheme. They used the standard sextant biopsy technique, and two additional lateral and three midline biopsies; an increased cancer detection rate of 35% was reported. Whilst cancer detection in these studies was improved by targeting the peripheral zone laterally and transition zone posteromedially, the present study emphasizes the importance of sampling the anterior compartment of the prostate to avoid missing clinically significant tumours. A prospective study is currently underway at our centre to examine whether targeting the anterior gland at biopsy increases the detection of prostate cancer.
In conclusion, tumours anterior to the urethra comprise a fifth of all prostate cancers treated by radical prostatectomy. In the present series, several sets of biopsies were more frequently required to diagnose these neoplasms. Furthermore, the biopsies of anterior tumours yielded smaller areas of cancer than posterior tumours in glands of similar weight and cancer burden. Prostate biopsy strategies should ensure adequate sampling of the anterior gland. If there is a high suspicion of cancer (rising PSA, free : total PSA ratio, PSA velocity) and biopsies are negative, the anterior gland should be targeted at subsequent biopsy.
